hasInternationalNonproprietaryName

P24556
predicate

Indicates that an entity (typically a pharmaceutical substance) is designated by a specific International Nonproprietary Name (INN) as its standardized generic name.

All labels observed (2)

Label Occurrences
hasInternationalNonproprietaryName canonical 22
hasNonproprietaryName 2

Description generation (PDg)

The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.

Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning.  
# Instructions
Focus on describing the relationship, not the entities themselves. 
# Response Format
Begin the description with \' Indicates...\'
Input
Predicate: hasInternationalNonproprietaryName
Generated description
Indicates that an entity (typically a pharmaceutical substance) is designated by a specific International Nonproprietary Name (INN) as its standardized generic name.

Sample triples (24)

Subject Object
Spinraza nusinersen ⓘ
linked to: Spinraza
Fampyra fampridine ⓘ
Tecentriq atezolizumab ⓘ
linked to: Tecentriq
Darzalex daratumumab ⓘ
mAb114 ansuvimab ⓘ
onasemnogene abeparvovec onasemnogene abeparvovec ⓘ
Tegsedi inotersen ⓘ
fampridine fampridine ⓘ
MabThera rituximab ⓘ
linked to: Rituxan
Avsola infliximab-axxq ⓘ
Onpattro patisiran ⓘ
linked to: Onpattro
Oxlumo lumasiran ⓘ
Amvuttra vutrisiran ⓘ
Xeljanz tofacitinib ⓘ
linked to: Xeljanz
Tagrisso osimertinib ⓘ
LOXO-292 selpercatinib ⓘ
Vitrakvi larotrectinib ⓘ
Retevmo selpercatinib ⓘ
Gleevec imatinib ⓘ
Venclexta venetoclax ⓘ
linked to: Venclexta
Alecensa alectinib ⓘ
infliximab-dyyb infliximab-dyyb via predicate surface "hasNonproprietaryName" ⓘ
Andexxa andexanet alfa via predicate surface "hasNonproprietaryName" ⓘ
fam-trastuzumab deruxtecan trastuzumab deruxtecan ⓘ